BCYC
Price
$8.34
Change
+$0.16 (+1.96%)
Updated
May 9 closing price
Capitalization
566.5M
82 days until earnings call
RCKT
Price
$6.99
Change
-$0.05 (-0.71%)
Updated
May 9 closing price
Capitalization
751.77M
93 days until earnings call
Ad is loading...

BCYC vs RCKT

Header iconBCYC vs RCKT Comparison
Open Charts BCYC vs RCKTBanner chart's image
Bicycle Therapeutics
Price$8.34
Change+$0.16 (+1.96%)
Volume$497.93K
Capitalization566.5M
Rocket Pharmaceuticals
Price$6.99
Change-$0.05 (-0.71%)
Volume$3.14M
Capitalization751.77M
BCYC vs RCKT Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. RCKT commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (BCYC: $8.34 vs. RCKT: $6.99)
Brand notoriety: BCYC and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 126% vs. RCKT: 108%
Market capitalization -- BCYC: $566.5M vs. RCKT: $751.77M
BCYC [@Biotechnology] is valued at $566.5M. RCKT’s [@Biotechnology] market capitalization is $751.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while RCKT’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • RCKT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BCYC and RCKT are a good buy in the short-term.

Price Growth

BCYC (@Biotechnology) experienced а -10.32% price change this week, while RCKT (@Biotechnology) price change was -12.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

BCYC is expected to report earnings on Jul 31, 2025.

RCKT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($752M) has a higher market cap than BCYC($566M). BCYC YTD gains are higher at: -40.429 vs. RCKT (-44.391). BCYC has higher annual earnings (EBITDA): -164.89M vs. RCKT (-247.48M). BCYC has more cash in the bank: 880M vs. RCKT (372M). BCYC has less debt than RCKT: BCYC (9.49M) vs RCKT (25.5M). BCYC has higher revenues than RCKT: BCYC (35.3M) vs RCKT (0).
BCYCRCKTBCYC / RCKT
Capitalization566M752M75%
EBITDA-164.89M-247.48M67%
Gain YTD-40.429-44.39191%
P/E RatioN/AN/A-
Revenue35.3M0-
Total Cash880M372M237%
Total Debt9.49M25.5M37%
FUNDAMENTALS RATINGS
BCYC vs RCKT: Fundamental Ratings
BCYC
RCKT
OUTLOOK RATING
1..100
2015
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8592
PRICE GROWTH RATING
1..100
6461
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (26) in the null industry is in the same range as RCKT (28) in the Biotechnology industry. This means that BCYC’s stock grew similarly to RCKT’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as RCKT (100) in the Biotechnology industry. This means that BCYC’s stock grew similarly to RCKT’s over the last 12 months.

BCYC's SMR Rating (85) in the null industry is in the same range as RCKT (92) in the Biotechnology industry. This means that BCYC’s stock grew similarly to RCKT’s over the last 12 months.

RCKT's Price Growth Rating (61) in the Biotechnology industry is in the same range as BCYC (64) in the null industry. This means that RCKT’s stock grew similarly to BCYC’s over the last 12 months.

RCKT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BCYC (100) in the null industry. This means that RCKT’s stock grew similarly to BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCRCKT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RDWBX11.280.02
+0.18%
American Funds Dvlpg Wld Gr&Inc R2
PGKAX24.47N/A
N/A
PGIM Jennison Technology A
PQIAX38.56N/A
N/A
Principal Equity Income A
SCSAX15.91N/A
N/A
Allspring Common Stock A
NIEYX16.69N/A
N/A
BNY Mellon International Equity Y

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with INO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+1.96%
INO - BCYC
55%
Loosely correlated
-1.10%
XNCR - BCYC
53%
Loosely correlated
-5.23%
RPTX - BCYC
51%
Loosely correlated
N/A
RLAY - BCYC
48%
Loosely correlated
N/A
RCKT - BCYC
46%
Loosely correlated
-0.71%
More